topoisomerase II inhibitors (Shanghai Institute of Materia Medica/Ocean University of China)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Nametopoisomerase II inhibitors (Shanghai Institute of Materia Medica/Ocean University of China)
Drug Alias Nametricitrinol Bcitrinin derivative (Shanghai Institute of Materia Medica/Ocean University of China)
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionTopoisomerase (DNA) II alpha inhibitors
TargetsTopoisomerase (DNA) II alpha
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of SciencesOcean University Of China
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A